GGGunnar Goerges

Gunnar Goerges

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gunnar Goerges has a total of 33 co-authors. Here are the top co-authors by number of shared publications:

  • Guiscard Seebohm

    8 shared publications
  • Bernhard Wünsch

    GRK 2515, Chemical biology of ion channels (Chembion) Universität Münster Münster Germany

    6 shared publications
  • Dirk Schepmann

    Universität Münster, Institut für Pharmazeutische Und Medizinische Chemie, Corrensstraße 48, Münster D-48149, Germany

    6 shared publications
  • Julian A. Schreiber

    Universität Münster, Institut für Pharmazeutische Und Medizinische Chemie, Corrensstraße 48, Münster D-48149, Germany

    5 shared publications
  • Bastian Frehland

    Institut für Pharmazeutische und Medizinische Chemie, Universität Münster, Corrensstraße 48, Münster D-48149, Germany

    4 shared publications
  • Judith Schmidt

    Universität Münster, Institut für Pharmazeutische Und Medizinische Chemie, Corrensstraße 48, Münster D-48149, Germany

    4 shared publications

Latest Publications

  • Open Access

    Poreadjacent mutations allow the host to silence viral potassium channel by reducing surface expression

    by Purva Asrani, Aladdin Elgendy, André P. Zeipelt, Gunnar Goerges, Julian A. Schreiber, Richard Brown, Daniel Todt, Daniel Tapken, Lars V. Schäfer, Guiscard Seebohm, et al.

    Lysogenic integration of viral genes into host genomes can generate evolutionary pressure that remodels viral protein function, yet the molecular principles underlying such host-driven modulation remain poorly understood. The potassium channel Kesv from Ectocarpus siliculosus virus (Kesv 1) and its host-derived orthologue (Kesv 2) differ by only seven residues but exhibit divergent functional expression. Here, we show that the brown algal host has accumulated pore-adjacent mutations that attenuate channel function by reducing surface expression rather than altering pore architecture. Using electrophysiology, GFP-tagged expression, mutagenesis, and stability simulations, we identify a pair of host-acquired substitutions (Q61H and T66A) that synergistically abolish functional expression despite preserving the canonical selectivity filter, tetramer stability, and overall structural fold. Pharmacological profiling further uncovers noncanonical activation by Sotalol and Linopirdine, establishing Kesv channels as minimalist systems for dissecting core ion channel modulation. Our findings reveal a previously unrecognized evolutionary strategy by which hosts suppress viral ion channel function through subtle, structure-preserving mutations.

  • Stereoselective Synthesis of Conformationally Restricted γ- and β-Amino Alcohols as GluN2B Subtype-Selective NMDA Receptor Antagonists

    by Marvin Korff, Gunnar Goerges, Judith Schmidt, Dirk Schepmann, Guiscard Seebohm, Julian A. Schreiber, Bernhard Wünsch

    A series of γ- and β-amino alcohols 6 and 15 was designed to restrict the corresponding conformationally flexible substructures found in the prototypical GluN2B-specific NMDA receptor inhibitors Ro 25-6981 (1) and ifenprodil (2). The diastereomerically pure cis- and trans-configured γ-amino alcohols 6 and β-amino alcohols 15 were prepared diastereoselectively from bicyclic ketones 4 and 10. Relationships between the structure (ring size, relative configuration, piperidine-OH-distance) and the GluN2B affinity were investigated. Usually, high GluN2B affinity translated into high inhibitory activity at the NMDA receptor. γ-Amino alcohol trans-6c displayed the highest selectivity over both σ receptors but was very fast metabolized in vitro. With respect to GluN2B affinity, inhibitory activity, ligand-lipophilicity efficiency (LLE), selectivity over σ1 receptors, and metabolic stability, β-amino alcohols cis-15a and trans-15b represent the most promising ligands of this series of compounds. However, both ligands displayed strong interactions with σ2 receptors indicating poor selectivity towards this receptor type.


  • Enantiomerically Pure Indazole Bioisosteres of Ifenprodil and Ro 25-6981 as Negative Allosteric Modulators of NMDA Receptors with the GluN2B Subunit

    by Judith Lüken, Gunnar Goerges, Julian A. Schreiber, Judith Schmidt, Bastian Frehland, Dirk Schepmann, Guiscard Seebohm, Bernhard Wünsch

    Administration of negative allosteric modulators of GluN2B subunit-containing NMDA receptors such as Ro 25-6981 (1) and ifenprodil (2) results in neuroprotective effects. In this study, the phenol of 1 and 2 was replaced bioisosterically by an indazole to inhibit glucuronidation. The γ- and β-aminoalcohols 10 and 11 were prepared without installing a protective group at the indazole ring using the ketone 6 as a common intermediate. All four stereoisomeric γ- and β-aminoalcohols 10 and 11 were obtained by diastereoselective reduction of ketones 7 and 9 followed by separation of enantiomers. The analogously structured γ-aminoalcohol (1S,2S)-10c (Ro 25-6981 bioisostere) and β-aminoalcohol (1R,2R)-11c (ifenprodil bioisostere) exhibited high GluN2B affinity (Ki = 50 and 66 nM, respectively) and high to moderate inhibitory activity in two-electrode voltage clamp experiments. The indazole bioisosteres 10 and 11 showed higher metabolic stability than 1. In the presence of uridinyldiphosphate activated glucuronic acid, glucuronidation of 10 and 11 was not observed.


  • Open Access

    A novel fluorescent labeling compound for GluN2A containing N-methyl-d-aspartate receptors identified by autodisplay-based screening

    by Alexander Dombovski, Ruben Steigerwald, Nadine Ritter, Paul Disse, Gunnar Goerges, Jana Osthues, Isabel Aymanns, Carina Dilkaute, Julian Schreiber, Martina Düfer, et al.


  • Negative allosteric modulators of NMDA receptors with GluN2B subunit: synthesis of β-aminoalcohols by epoxide opening and subsequent rearrangement

    by Marvin Korff, Judith Lüken, Judith Schmidt, Dirk Schepmann, Gunnar Goerges, Nadine Ritter, Paul Disse, Julian A. Schreiber, Guiscard Seebohm, Bernhard Wünsch

    In order to obtain novel antagonists of GluN2B subunit containing NMDA receptors, aryloxiranes were opened with benzylpiperidines. Phenyloxiranes 6 and (indazolyl)oxirane 15 were opened regioselectively at the position bearing the aryl moiety. Reaction of the resulting β-aminoalcohols 7 and 16 with carboxylic acids under Mitsunobu conditions (DIAD, PPh3) led to rearrangement and after ester hydrolysis to the regioisomeric β-aminoalcohols 9 and 18. This strategy allows the synthesis of amino-ifenprodil 12 as well using phthalimide in the Mitsunobu reaction. Unexpectedly, the isomeric (indazolyl)oxirane 21 reacted with benzylpiperidines to afford both regioisomeric β-aminoalcohols 22 and 23. In radioligand receptor binding studies, the indazolyl derivative 18a, which can be regarded as indazole bioisostere of ifenprodil, showed high GluN2B affinity (Ki = 31 nM). Replacement of the benzylic OH moiety of ifenprodil by the NH2 moiety in amino-ifenprodil 12 also resulted in low nanomolar GluN2B affinity (Ki = 72 nM). In TEVC experiments, 18a inhibited the ion flux to the same extent as ifenprodil proving that the phenol of ifenprodil can be replaced bioisosterically by an indazole ring maintaining affinity and inhibitory activity. Whereas 10-fold selectivity was found for the ifenprodil binding site over σ1 receptors, only low preference for the GluN2B receptor over σ2 receptors was detected. The log D7.4 value of 18a (log D7.4 = 2.08) indicates promising bioavailability.


  • Indazole as a Phenol Bioisostere: Structure–Affinity Relationships of GluN2B-Selective NMDA Receptor Antagonists

    by Judith Lüken, Gunnar Goerges, Nadine Ritter, Paul Disse, Julian A. Schreiber, Judith Schmidt, Bastian Frehland, Dirk Schepmann, Guiscard Seebohm, Bernhard Wünsch

    Negative allosteric modulation of GluN2B subunit-containing NMDA receptors prevents overstimulation, resulting in neuroprotective effects. Since the phenol of prominent negative allosteric modulators is prone to rapid glucuronidation, its bioisosteric replacement by an indazole was envisaged. The key step in the synthesis was a Sonogashira reaction of non-protected iodoindazoles with propargylpiperidine derivatives. Modification of the alkynyl moiety allowed the introduction of several functional groups. The synthesized indazoles showed very high GluN2B affinity but limited selectivity over σ receptors. Molecular dynamics simulations revealed the same molecular interactions with the ifenprodil binding site as the analogous phenols. In two-electrode voltage-clamp experiments, enantiomeric 3-(4-benzylpiperidin-1-yl)-1-(1H-indazol-5-yl)propan-1-ols (S)-10a and (R)-10a displayed higher inhibitory activity than ifenprodil. In contrast to phenolic GluN2B antagonists, the indazoles were not conjugated with glucuronic acid. It can be concluded that the phenol of potent GluN2B antagonists can be replaced bioisosterically by an indazole, retaining the high GluN2B affinity and activity but inhibiting glucuronidation.


  • Open Access

    Phenol‐benzoxazolone bioisosteres of GluN2B‐NMDA receptor antagonists: Unexpected rearrangement during reductive alkylation with phenylcyclohexanone

    by Alexander Markus, Julian A. Schreiber, Gunnar Goerges, Bastian Frehland, Dirk Schepmann, Constantin Daniliuc, Roland Fröhlich, Guiscard Seebohm, Bernhard Wünsch

    Negative allosteric modulators of N‐methyl‐ d‐aspartate receptors containing the GluN2B subunit represent promising drug candidates for the treatment of various neurological disorders including stroke, epilepsy, and Parkinson's disease. To increase the bioavailability and GluN2B affinity, the phenol of the potent benzazepine‐based inhibitor, WMS‐1410 (3), was replaced bioisosterically by a benzoxazolone moiety and the phenylbutyl side chain was conformationally restricted in a phenylcyclohexyl substituent. A four‐step, one‐pot procedure transformed the oxazolo‐benzazepine 7 into the phenylcyclohexyl derivative 11. The same protocol was applied to the methylated analog 12, which unexpectedly led to ring‐contracted oxazolo‐isoquinolines 18. This rearrangement was explained by the additional methyl moiety in the 8‐position inhibiting the formation of the planar intermediate iminium ion with phenylcyclohexanone. The allyl protective group of 11 and 18 was removed with RhCl3 and HCl to obtain the tricyclic compounds 5 and 19 without substituent at the oxazolone ring. The structures of the rearranged products 18 and 19 were elucidated by X‐ray crystal structure analysis. The oxazolo‐isoquinoline trans‐18 with allyl moiety (Ki = 89 nM) and the oxazolo‐benzazepine 5 without substituent at the oxazolone ring (Ki = 114 nM) showed GluN2B affinity in the same range as the lead compound 3. In two‐electrode voltage clamp measurements, 5 displayed only weak inhibitory activity.


  • Open Access

    Phenol—Benzoxazolone bioisosteres: Synthesis and biological evaluation of tricyclic GluN2B‐selective N‐methyl‐d‐aspartate receptor antagonists

    by Alexander Markus, Julian A. Schreiber, Gunnar Goerges, Bastian Frehland, Guiscard Seebohm, Dirk Schepmann, Bernhard Wünsch

    Tricyclic tetrahydrooxazolo[4,5‐h]‐[3]benzazepin‐9‐ols 22 were designed as phenol bioisosteres of tetrahydro‐3‐benzazepine‐1,7‐diols. Key features of the synthesis are the introduction of the trifluoromethylsulfonyl and allyl protective groups at the heterocyclic N‐atoms. Two methods were developed to convert the triflyl‐protected ketone 16 into tricyclic alcohols 21 bearing various N‐substituents. According to the first method, trifluoromethanesulfinate was removed by K2CO3. Following the selective reduction of the imino moiety of 17 with NaBH(OAc)3 afforded the aminoketone 18, which was reductively alkylated and reduced. According to the second method, both the imine and the ketone of the iminoketone 17 were reduced with NaBH4 to yield the aminoalcohol 20, which was alkylated or reductively alkylated to form tertiary amines 21f–21r. In the last step, the allyl protective group of 21 was removed with RhCl3 and HCl to obtain oxazolones 22. In receptor binding studies using [3H]ifenprodil as radioligand ketone, 22m showed the highest GluN2B affinity (Ki = 88 nM). However, a reduced affinity toward GluN2B subunit‐containing N‐methyl‐ d‐aspartate (NMDA) receptors was observed for oxazolones 22 compared to bioisosteric 3‐benzazepine‐1,7‐diols. High selectivity of 22m for the ifenprodil binding site of GluN2B‐NMDA receptors over the 1‐(1‐phenylcyclohexyl)piperidine binding site and σ2 receptors was observed, but only negligible selectivity over σ1 receptors. In two‐electrode voltage clamp experiments, the 4‐phenylbutyl derivative 22d (Ki = 422 nM) demonstrated 80% inhibition of ion flux at a concentration of 1 µM. The differences in GluN2B affinity and inhibitory activity are explained by docking studies. In conclusion, 22d is regarded as a novel scaffold of highly potent GluN1/GluN2B antagonists.